News

Patients are discussing whole-body MRIs on Reddit, presenting opportunity for radiologists

“Radiologists are well-positioned to contribute evidence-based guidance, promote transparency, and help patients make informed decisions," experts write in Clinical Imaging.

Lumexa acquires imaging center as part of new joint venture with UPMC

Lumexa hopes to open between 8 to 10 newly constructed, “de novo” centers in 2026, including multiple ones built in partnership with UPMC.

Novel urine test reduces need for MR imaging, prostate biopsies

Vanderbilt experts have developed an assessment called MyProstateScore 2.0, which they say performs better than regular PSA-based testing and MRI for monitoring low-risk disease.

Investor-bought PCPs carry on like nothing much has changed—with caveats

Private-equity acquisitions of primary-care provider practices neither alter hospitalization rates nor affect acute-care outcomes, according to new research out of Brown University.

12 of the top technology vendors serving children’s hospitals

Epic makes the list with its enterprise inpatient EHR and related platforms. So does PCC, aka Physician’s Computer Company, which supplies pediatric-specific ambulatory EHR and practice-management products and services.

Siemens Healthineers nabs FDA clearance for 6 new IR systems

Siemens Healthineers scores FDA clearance for 6 interventional systems

Each device comes equipped with a new AI feature designed to deliver high quality imaging at lower radiation doses during IR procedures.

Half of emergency CT requests for children may not adhere to imaging appropriateness criteria

The overuse of CT scans on kids could be owed, at least in part, to the fear of missing a critical finding, new research suggests.

Is TAVR too common among younger patients? New data prompt a ‘call to action’

Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Bayer's new imaging agent for cardiac amyloidosis impresses in clinical trial

The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.

Florida doctor charged with manslaughter in patient death describes chaotic scene in deposition

Thomas Shaknovsky, MD, is accused in a civil lawsuit of removing a patient’s liver instead of spleen, causing his death. The surgeon, who lost his license to practice medicine in Florida, has also been criminally charged with second degree manslaughter. He denies any intentional wrongdoing.

Former healthcare CEO sentenced to 5 years in prison for role in $212M fraud conspiracy

Parmjit “Paul” Parmar, 55, from New Jersey has also been ordered to pay $125 million in restitution. The scheme to defraud investors was uncovered in 2017.

AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Around the web

Radiology Business

Patients are discussing whole-body MRIs on Reddit, presenting opportunity for radiologists

“Radiologists are well-positioned to contribute evidence-based guidance, promote transparency, and help patients make informed decisions," experts write in Clinical Imaging.

Radiology Business

Lumexa acquires imaging center as part of new joint venture with UPMC

Lumexa hopes to open between 8 to 10 newly constructed, “de novo” centers in 2026, including multiple ones built in partnership with UPMC.

Radiology Business

Novel urine test reduces need for MR imaging, prostate biopsies

Vanderbilt experts have developed an assessment called MyProstateScore 2.0, which they say performs better than regular PSA-based testing and MRI for monitoring low-risk disease.